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The non-peer-reviewed biomonitoring report published online by Moms Across America (MAA; Hon-
eycutt and Rowlands, 2014) does not support the conclusion that glyphosate concentrations detected in a
limited number of urine samples from women, men and children, or breast milk from nursing mothers,
pose a health risk to the public, including nursing children. Systemically absorbed doses of glyphosate
estimated from the MAA urine biomonitoring data and from other published biomonitoring studies
indicate that daily glyphosate doses are substantially below health protective reference standards (ADIs;
RfDs) established by regulatory agencies. The MAA report also suggested that detection of relatively high
glyphosate concentrations in breast milk in 3 of 10 sampled women raised a concern for bioaccumulation
in breast milk. However, the breast milk concentrations reported by MAA are highly implausible when
considered in context to low daily systemic doses of glyphosate estimated from human urine bio-
monitoring data, and also are inconsistent with animal toxicokinetic data demonstrating no evidence of
retention in tissues or milk after single- or multiple-dose glyphosate treatment. In addition, toxicokinetic
studies in lactating goats have shown that glyphosate does not partition into milk at concentrations
greater than blood, and that only a very small percentage of the total administered dose (<0.03%) is
ultimately excreted into milk. The toxicokinetic studies also indicate that human glyphosate exposures
estimated from urine biomonitoring fall thousands-of-fold short of external doses capable of producing
blood concentrations sufﬁcient to result in the breast milk concentrations described in the MAA report.
Finally, in contrast to highly lipophilic compounds with bioaccumulation potential in breast milk, the
physico-chemical properties of glyphosate indicate that it is highly hydrophilic (ionized) at physiological
pH and unlikely to preferentially distribute into breast milk.
© 2016 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
In April of 2014, Honeycutt and Rowlands (2014), under spon-
sorship of the non-governmental organizations Moms Across
America (MAA) and Sustainable Pulse, described the results of a
non-peer-reviewed report (Internet posting) in which glyphosate
was detected in breast milk of 3 of 10 women located in Florida
(166 mg/L), Virginia (76 mg/L) and Oregon (99 mg/L). In addition,
glyphosate was detected in 13 of 35 urine samples from women
residing in Oregon, California, Washington, Maryland, Colorado,
and Hawaii, with the highest urine concentration (18.8 mg/L)Inc. This is an open access articledetected in a woman from Oregon. The report concluded that the
relatively high concentrations of glyphosate detected in breast milk
suggested bioaccumulation, and thus posed potential health
threats to nursing children. Importantly, however, the report itself
acknowledged that the “initial testing” was “not meant to be a full
scientiﬁc study” and was primarily intended to catalyze further in-
depth analyses and understanding of the potential health signiﬁ-
cance of glyphosate detection in breast milk. Such a precaution is
consistent with cautions from the Centers for Disease Control and
Prevention and the National Academy of Science/National Research
Council (NAS/NRC) that simple detection of environmental sub-
stances in human biomonitoring samples does not necessarily
indicate disease-causing potential. Rather, examination ofunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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toxicity data, as well as established health-protective reference
standards, is necessary to understanding when biomonitoring data
suggest potential health effects (NAS/NRC, 2006; CDC, 2009;
Aylward et al., 2013).
A non-peer-reviewed May 2014 analysis of the MAA report by
Dr. Ron Kleinman, the physician-in-chief of Massachusetts General
Hospital for Children, and Chair of the Department of Pediatrics at
Massachusetts General Hospital, has offered two signiﬁcant
methodological concerns associated with the report (Kleinman,
2014). First, the milk analyses relied on an antibody-based assay
(ELISA) that was developed originally for qualitativewater analyses,
and the report was silent concerning key technical details
regarding whether the method was speciﬁcally standardized and
calibrated for milk assays in the range of glyphosate levels reported
in the report. Second, sample quality concerns arise in that limited
details were provided as to how the samples were obtained (e.g.,
details of selection of study participants), shipped, stored, and ul-
timately processed by the receiving analytical laboratory. These
methodological concerns can be resolved only by generating or
providing additional experimental ﬁndings and further clarifying
the demographic details of sample sources and chain-of-custody
protocols. The U.S. EPA also noted these deﬁciencies and others in
a letter sent to MAA (U.S. EPA, 2014).
Beyond the methodological concerns, the present analysis
demonstrates how an integrated evaluation of animal tox-
icokinetics, human biomonitoring and exposure data, and the
physico-chemical properties of glyphosate reveals that the con-
centrations of glyphosate reported in the three samples of breast
milk (76, 99, and 166 mg/L) are implausibly high and not attainable
under realistic glyphosate exposure scenarios. This analysis also
demonstrates that glyphosate does not bioaccumulate in breast
milk. Other integrated evaluations of the overall body of glyphosate
toxicology and exposure data have likewise concluded that external
daily doses of glyphosate, as determined from human bio-
monitoring data or projected from exposure modeling, do not
present unacceptable health risks to the public, including nursing
children (U.S. EPA, 1993; Williams et al., 2000; McQueen et al.,
2012; U.S. EPA, 2013; Niemann et al., 2015). A recent WorldTable 1
Recovery of 14C-glyphosate in urine, feces, and tissues as a percentage of administered d
Dose Species Urine Feces
Male Female Male
Single dose, pob
6.7 mg/kg, 120 ha Rat 14e16 35e43 81e85
10 mg/kg, 24/48 h Rat 17.9/34.0 12.8/12.5 59.3/60.5
10 mg/kg, 72 h Rat 13.0 10.6 88.5
10 mg/kg, 168 h Rat 28.6 22.5 62.4
30 mg/kg, 168 h Rat 29.04 30.71 58.84
1000 mg/kg, 72 h Rat 16.7 17.5 89.6
1000 mg/kg, 168 h Rat 30.55 22.41 53.27
5.7e8.8 mg/kg, 120 h Rabbit 7e11 ND 80e97
Single dose, ipb
2.3e3.6 mg/kg, 120 h Rat 82.90 ND 6e14
Single dose, ivb
10 mg/kg, 168 h Rat 79.0 74.5 4.65
30 mg/kg, 168 h Rat 85.98 84.18 3.42
Single dose, imb
4 mg/animal, 168 h Monkey 89.9 ND ND
Repeated dose, pob
10 mg/kg, 72 hc Rat 10.6 10.7 86.6
10 mg/kg, 168 hc Rat 30.9 23.1 61.0
30 mg/kg, 168 hc Rat 34.28 34.63 49.64
400 mg/goat, 120 h Goat ND 9.44 ND
a Radioactivity collection times after dosing, hr.
b ND ¼ Not Determined; po ¼ oral gavage ip ¼ intraperitoneal; iv ¼ intravenous; im
c 14 days of unlabeled glyphosate dosing followed by single radiolabelled dose.Health Organization (WHO) International Agency for Research on
Cancer (IARC) decision that glyphosate is a “probable” (IIA) human
carcinogen (Guyton et al., 2015) did not include consideration of
real-world glyphosate exposures and contradicts decades of in
depth regulatory reviews (PMRA, 1991; U.S. EPA, 1993; EC, 2002;
APVMA, 2013; U.S. EPA, 2013; PMRA, 2015) as well as previous
WHO expert committee reviews that have consistently declared
that glyphosate is not carcinogenic (WHO IPCS, 1994; WHO JMPR,
2004; WHO, 2005). Although the MAA report has called for a
more in-depth evaluation of potential health concerns as a result of
their reported detection of glyphosate in human breast milk and
urine, this report illustrates how such concerns can be addressed by
an integrated analysis of available animal and human toxicokinetic,
biomonitoring, and toxicity data.
2. Animal toxicokinetic (absorption, distribution,
metabolism, and elimination; ADME) data do not indicate that
glyphosate has bioaccumulation potential in human breast
milk
The toxicokinetics and metabolism of glyphosate have been
extensively characterized and reported in series of single- and
multiple-dose studies conducted in rats and other animal species
(Brewster et al., 1991; reviewed in Williams et al., 2000; WHO
JMPR, 2004; Anadon et al., 2009). As shown in the various data-
sets summarized in Table 1 (modiﬁed from WHO JMPR, 2004),
these studies consistently demonstrate that approximately 20e30
percent of orally administered glyphosate (as 14C-glyphosate) is
absorbed at doses between 6.7 and 1000 mg/kg, with the
remainder of the ingested dose excreted in feces. Recovery of total
administered radioactivity in urine and feces is largely complete by
48 h after dosing, indicating rapid clearance of absorbed (urine) and
non-absorbed (fecal) glyphosate. Importantly, Howe et al. (1988,
reviewed in WHO JMPR, 2004), using highly sensitive and speciﬁc
chromatographic (cation-exchange and ion-pair HPLC) and spec-
troscopic (1H-NMR, 13P-NMR and mass spectrometry) techniques,
conﬁrmed that glyphosate experienced very limited overall meta-
bolism following oral 10 mg/kg doses in male and female rats.
Glyphosate represented 98.5 to 99.3 percent of the totalose following oral or parenteral administration (modiﬁed from WHO JMPR, 2004).
Tissues Reference
Female Male Female
49e55 0.14e0.65 0.83e1.02 Colvin and Miller (1973)
80.3/91.2 NDb ND Davies (1996a)
88.7 0.59 0.49 Davies (1996a)
69.4 0.44 0.31 Ridley and Mirly (1988)
56.53 0.62 0.64 Powles (1992)
84.5 0.52 0.58 Davies (1996b)
60.37 0.47 0.40 Powles (1992)
ND 0.1e1.2 ND Colvin and Miller (1973)
ND 0.53e1.00 ND Colvin and Miller (1973)
8.3 1.27 1.09 Ridley and Mirly (1988)
1.48 1.35 1.09 Powles (1992)
ND ND ND Maibach (1983)
90.7 0.46 0.41 Davies (1996c)
70.9 0.54 0.35 Ridley and Mirly (1988)
46.73 0.96 0.83 Powles (1992)
78.16 ND ND Powles (1994)
¼ intramuscular.
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of the metabolite aminomethylphosphonic acid (AMPA) were
detected. The limited metabolism of glyphosate was attributed to
gut microﬂora metabolism, because AMPA was not observed in
urine following intravenous administration of glyphosate (Howe
et al., 1988). An unpublished ADME study in bile-cannulated rats
found that less than 0.08% of an oral 1 mg/kg glyphosate dose in
rats was recovered in bile, indicating that excretion of glyphosate in
the feces was due to a lack of absorption and not to enterohepatic
elimination (Knowles and Mookherjee, 1996). The ﬁndings of these
unpublished studies have been conﬁrmed by Brewster et al. (1991),
in which a similar oral versus fecal excretion pattern (36% urine,
51% feces), rapid clearance in urine and feces, and limited meta-
bolism to AMPA (<0.1%) were observed following a single oral
10 mg/kg dose of glyphosate to rats. More recently, Anadon et al.
(2009) reported an oral bioavailability of 23.2% in rats treated
with 100 mg/kg glyphosate. A signiﬁcant consideration affecting
glyphosate systemic toxicokinetics is that glyphosate was shown to
rapidly distribute into water-rich body compartments, after which
ﬂux was reversed as rapid excretion proceeded. This dynamic is
clearly distinguished from bioaccumulation, where ﬂux would not
be rapidly reversed, and complete and rapid levels of excretion
would not be overtly evident. The extensive and rapid clearance of
unmetabolized glyphosate into urine signiﬁcantly facilitates inter-
pretation of human biomonitoring studies, in that 24-h urine col-
lections are representative of total systemic daily doses of
glyphosate.
The glyphosate toxicokinetic proﬁle described above is entirely
consistent with a compound having no bioaccumulation potential.
Repeated-dose (15-day) toxicokinetic studies conducted at 10 or
30 mg/kg/day glyphosate (Table 1) also demonstrate an absorption
and excretion proﬁle essentially identical to that of single-dose
administration. This further reinforces the conclusion that glyph-
osate lacks bioaccumulation potential. In addition, residual radio-
activity remaining in the tissues was very low and equivalent in
each tissue following either single- or repeated-dose administra-
tion of 14C-glyphosate. The lack of glyphosate bioaccumulation
potential in breast milk, a lipid (fat)-rich tissue, is supported by the
representative single- or repeated-dose tissue distribution data
obtained from the Ridley and Mirly (1988) toxicokinetic study in
rats (Table 2; reviewed inWHO JMPR, 2004). Only trace amounts of
radioactivity were detected in a spectrum of tissues collected 168 h
after oral dosing of 14C-glyphosate. Residual radioactivity in blood,Table 2
Mean tissue concentrations of radioactivity (ppm) determined 168 h after single or
repeated oral gavage administration of 10 or 1000 mg/kg14C-glyphosate in rats
(modiﬁed from WHO JMPR, 2004)a.
10 mg/kg single
dose
10 mg/kg
repeated doseb
1000mg/kg single
dose
Tissue Male Female Male Female Male Female
Whole blood 0.004 0.003 0.005 0.003 0.328 0.166
Liver 0.030 0.014 0.041 0.026 1.91 1.37
Brain 0.007 0.006 0.014 0.011 0.750 0.556
Kidney 0.022 0.013 0.033 0.020 1.94 1.35
Lung 0.015 0.012 0.012 0.017 1.54 1.13
Testes/Ovaries 0.003 0.003 0.005 0.008 0.363 0.572
Stomach 0.008 0.004 0.038 0.024 2.38 2.36
Colon 0.034 0.016 0.043 0.030 11.0 9.2
Bone 0.552 0.313 0.748 0.462 30.6 19.7
Muscle 0.002 0.002 0.003 0.002 0.262 0.214
Fat 0.004 0.003 0.006 0.006 0.418 0.457
Carcass 0.106 0.087 0.157 0.101 8.27 7.74
a Selected tissue data from Ridley and Mirly (1988); tissue concentrations (ppm)
are rounded values.
b 14 days of unlabeled daily gavage administration of glyphosate dosing followed
by a single radiolabeled dose.the distribution compartment of glyphosate to distal systemic tis-
sues/ﬂuids, including breast milk, was generally low and equivalent
to levels in all tissues, including abdominal fat. The only exception
to this general observation was that residual radioactivity in bone
was slightly higher than that seen in other tissues.
An absence of glyphosate bioaccumulation in milk has been
demonstrated directly in a distribution and mass balance investi-
gation conducted in two lactating goats given repeated oral
(capsule gavage) daily doses of approximately 8 and 6 mg/kg,
respectively, of 14C-glyphosate for 5 and 3 consecutive days (un-
published report of Powles 1994; reviewed in WHO JMPR, 2004).
The goats were milked twice daily, and milk was pooled for
determination of total daily glyphosatemilk excretion. Total excreta
were collected over 24 h intervals after the ﬁrst dose; the ﬁrst goat
was euthanized 23.5 h after the last dose, and the second goat was
euthanized 8 h after the ﬁnal dose. The overall excretion proﬁle of
radioactivity was similar to the results from rats, with approxi-
mately 78% of dosed radioactivity recovered in feces and 12% in
urine and cage-wash/debris in the ﬁrst goat. Clearance of radioac-
tivity from tissues after termination of dosing was rapid; only 0.05%
of the administered dose was recovered in tissues 23.5 h after the
last dose to the ﬁrst goat. Again paralleling rat data, glyphosate
represented 94e96 percent of the total radioactivity recovered in
urine and feces, as conﬁrmed by HPLC and Fourier-transform
infrared spectroscopy; thin-layer chromatography tentatively
identiﬁed AMPA as a minor urine and fecal metabolite. Importantly,
total radioactivity recovered in milk over the course of the three to
ﬁve daily treatments represented only 0.03% of the total adminis-
tered dose in both goats. Peak concentrations of radioactivity in
milk were 72 and 86 mg (glyphosate)/L (milk) for each respective
goat and were less than the peak blood concentrations of
102e101 mg (glyphosate)/L (blood) observed 6e8 h after the last
dose in the second goat. These data demonstrate that glyphosate is
not selectively taken up and/or retained in breast milk relative to
blood concentrations or other body tissues. The ﬁndings of Powles
(1994) were replicated in a similar study in which three lactating
goats were administered a combination of 14C/13C-radiolabeled
glyphosate and AMPA (glyphosate average dose of 5 mg/kg/day;
AMPA 0.5 mg/kg/day) for 5 consecutive days (Bodden 1988;
reviewed in Williams et al., 2000). Peak total radioactivity con-
centrations in pooled daily milk collections were the equivalent of
35, 38, and 86 mg glyphosate/L, and reached steady state by the
second day of dosing. Using very precise radiolabel analysis, it was
demonstrated that glyphosate collected in milk represented less
than 0.01% of the total administered dose of glyphosate in all three
goats, and the concentration of glyphosate decreased rapidly, from
38 mg/L to 6 mg/L during a 5-day post-treatment period in one goat.
The goat data directly show that only small amounts of glyph-
osate are distributed into breast milk, which, when coupled with
rapid urinary clearance following termination of dosing in both rats
and goats, further demonstrate that glyphosate does not bio-
accumulate in tissues or breast milk.
3. Glyphosate breast milk concentrations reported in 3 of 10
women in the MAA report (Honeycutt and Rowlands, 2014)
are biologically implausible when compared to systemic and
external doses estimated from urine biomonitoring ﬁndings,
or from blood concentrations resulting from such doses
Systemic and/or external doses of glyphosate associated with
occupational and incidental/dietary exposures to glyphosate have
been investigated in two U.S.-based biomonitoring studies
(Acquavella et al., 2004; Curwin et al., 2007; reviewed in Niemann
et al., 2015). Niemann and coworkers (2015) summarized the daily
average or maximum urine concentrations from these
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of mean and/or maximum doses of systemic (orally absorbed) and/
or total external dietary doses of glyphosate, and compared these
dose estimates to those projected from the maximum urine con-
centration. (18.8 mg/L) reported in the limited MAA report (Table 3).
Using urine concentrations detected in 48 farmer/applicators in
Minnesota and South Carolina during the day of, and the immediate
3 days after engaging in glyphosate agricultural spraying opera-
tions (Acquavella et al., 2004), Niemann and coworkers (2015)
calculated mean and maximum glyphosate systemic doses of 0.11
and 8.3 mg/kg/day, respectively (Table 3). Although the geometric
mean systemic dose in farmer/applicators was low, the maximum
dose in the Acquavella et al. (2004) study was measured in a single
farmer who engaged in lengthy repairs to the boom sprayer, had
evidence of spills while mixing and loading, and was observed not
using protective gloves. The maximum urine concentration and
systemic dose observed in a “child” (29 ppm; 0.8 mg/kg/day) was
measured in the teenage sonwho assisted the same farmer (father).
Acquavella and coworkers (2004) also reported urinary glyphosate
detection in two spouses (4% of those measured) on the day of
application, and calculated a maximum systemic dose of 0.04 mg/
kg/day. Both spouses and children lived near the glyphosate mix-
ing/loading and spraying activities, so these individuals likely
represented a high-exposure scenario relative to the general pop-
ulation. This study also found that urine concentrations declined
substantially during the immediate 3 day post-application period,
which was consistent with ﬁndings in animal studies demon-
strating rapid and complete urinary excretion of glyphosate.
Curwin et al. (2007) measured glyphosate urine concentrations
in Iowa farm and non-farm families within 1e5 days of a pesticide
application operation. Urine concentrations were generally in the
same range as those reported in Acquavella et al. (2004), andTable 3
Glyphosate concentrations in human urine samples (mean and maximum) and calculated
are well below RfDs established as health protective, including to children: EPA (2003
(modiﬁed from Niemann et al., 2015).
Study Study Participants Group
Acquavella et al. (2004) 48 male farmers, spouses, 79 children
from farm families
Farmer
Child
Spouse
Curwin et al. (2007) 47 farmers, 48 mothers, 117 children
from farm and non-farm families in Iowa
All Groups
Mothers (a
- Farm
- Non-Far
McQueen et al. (2012) 20 pregnant non-farm, Australia Pregnant w
(non-biom
composite
Honeycutt and
Rowlands (2014)
35 women, men, children, across US Across all
Honeycutt and
Rowlands (2014)
10 women, across US Infants, 5
a Systemic doses of glyphosate calculated by or using formula of Niemann et al. (2015
b Total external dietary daily doses of glyphosate calculated by Niemann et al. (2015) a
dose of glyphosate was systemically absorbed.
c Systemic dose calculations from Acquavella et al. (2004) which used bodyweights of i
of application, and all but 1 was present at or participated in mixing/loading operations; m
applicator. Glyphosate was detected only in 2 spouses.
d Not Determined.
e Not applicable.
f External doses estimated from analysis of glyphosate in composite diets of the individ
2015) ¼ 0.2 mg/kg/day (mean) and 1.0 mg/kg/day (maximum).
g Maximum 166 mg/L breast milk concentration is highly implausible based on glyphos
(see text); estimated maximum dose of 33 mg/kg/day is highly implausible, yet still welltranslated to essentially the same highest mean systemic dose of
0.1 mg/kg/day and a highest mean external dietary dose of 0.5 mg/
kg/day (Table 3). Glyphosate urine concentrations were essentially
the same in farm and non-farm families, and were not affected by
whether the father engaged directly in glyphosate spraying oper-
ations. For farmmothers, urinary glyphosate concentrations did not
correlate with farm size, number of acres or amount applied, or the
number of days since the last applications, possibly consistent with
rapid clearance from the body and the 1e5 day interval windows
between glyphosate applications and urine sampling.
The maximum urine concentration described in the MAA report
(18.8 mg/L; Honeycutt and Rowlands, 2014) was in the range of the
maximumvalues reported for the other two biomonitoring studies,
and was converted to a maximum external daily dietary dose of
3.3 mg/kg/day and a 0.66 mg/kg/day systemic dose (Table 3). The
geographic location data (state and zip code) described in the MAA
report indicate that none of the three women with detectable
glyphosate in breast milk were simultaneously evaluated for
glyphosate in urine. However, given the glyphosate toxicokinetic
and physico-chemical property considerations outlined below, it is
highly unlikely that the three women with detected glyphosate in
breast milk could have had urine concentrations correlating to
blood concentrations sufﬁcient to result in the reported breast milk
concentrations. In addition, the 18.8 mg/L maximum urine con-
centration reported by MAA likely represents a reasonable peak
general-population urine value, in that it is in the range of
maximum concentrations seen in the other two more compre-
hensive biomonitoring studies, and is substantially higher than
geometric mean urine glyphosate concentrations reported for
exposure scenarios encompassing direct engagement in glyphosate
application operations or families living in proximity to such ac-
tivities (Table 3).estimates of systemic and external doses. All estimated systemic and external doses
) ¼ 1,750 mg/kg/day; European Food Safety Authority (proposed) ¼ 500 mg/kg/day
Urine concentrations (mg/L) Estimated systemic
dosea or external
doseb (mg/kg/day)
Geometric mean Maximum Mean Maximum
3.2 233 0.11a 8.3a (4.0c)
NDd 29c NDd 0.8c
NDd 3c NDd 0.04c
1.1e2.7 18 NDd 0.1a (adult)
ll) 1.1e1.5 NDd 0.5b (adult)
1.1e1.5 11 NDd 0.17a
m 1.2 5 NDd 0.36a
omen
onitored;
food analysis)
NAe NAe 1f 5f
groups NDd 18.8 NDd 0.66a
3.3b
Breast Milk Concentration
(mg/L)
External Dose to 5 kg
Infant (mg/kg/day)
kg body weight NDd 166g NDd 33g
); assume 2 L of urine per day and 60 kg body weight.
ssuming, using data from animal toxicokinetic studies, that 20% of the external daily
ndividual study participants. 9 of 78 Children had detectable urine glyphosate on day
aximum urine concentration observed in a single teenage child who assisted father/
ual women; systemic dose assumes 20% absorption of external dose (Niemann et al.,
ate animal toxicokinetic, physico-chemical property and human biomonitoring data
below any country's acceptable daily intake for humans including nursing children.
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studies with urine biomonitoring data reported by MAA reveals that
the concentrations of glyphosate reported in breastmilk (76e166 mg/
L) of 3 of 10 women in the MAA report are highly implausible. The 6
and8mg/kgdosesused in thegoat toxicokinetic study (Powles1994),
despite being 1,818- and 2,424-fold higher than the maximum
external glyphosate dose of 3.3 mg/kg/day estimated from the MAA
urine biomonitoring data (Table 3), resulted in peak milk concen-
trations (72 and 86 mg/L) approximating those described in the MAA
report. In a rat toxicokinetic study (Brewster et al., 1991), glyphosate
blood concentration peaked at 0.38% of the administered dose of
10 mg/kg 2 h after dosing, which results in an estimated blood con-
centration of 0.475 mg/mL (10 mg/kg dose to 0.125 kg rats¼ 1.25 mg
administered dose; 0.38% of dose¼ 0.00475mg¼ 4.75 mg; rat blood
volume ¼ 8% body weight ¼ 10 mL; blood concentration ¼ 4.75 mg/
10 mL ¼ 0.475 mg/mL ¼ 475 mg/L). The 475 mg/L peak blood concen-
tration in rats, which is an expectedly higher blood concentration
than theapproximate100mg/Lpeakobserved inagoatdosedat6mg/
kg, converts to an estimated milk concentration in rats of about
380 mg/L (assuming a parallel ratio of peak blood:milk concentration
observed for goats of 1:0.8). Similarly to goats, the rat dose of 10mg/
kg (10,000 mg/kg), which is 3,030-fold higher than the maximum
external dose of 3.3 mg/kg/day described in the MAA report, would
result in only 2- to 5-fold estimated higher milk concentrations
(380 mg/L vs 76e166 mg/L). Assuming similar oral absorption kinetics
and blood:milk distribution ratios between goats, rats and humans,
the goat and rat toxicokinetic data indicate the milk concentrations
reported in theMAA studywould have required external glyphosate
doses improbably higher (e.g., greater than 1,000-fold) than the low
mg/kg/day glyphosate doses identiﬁed in the MAA and other urine
biomonitoring datasets (Table 3).
The above conclusions derived from comparisons of the animal
toxicokinetic and human biomonitoring data also are consistent
with ﬁndings from a dietary exposure investigation in pregnant
women. Glyphosate residues in composites of foods directly
consumed by the women translated to an estimated dietary daily
dose of 0.001 mg/kg/day (1 mg/kg/day), in close agreement with
exposures predicted from biomonitoring studies (McQueen et al.,
2012, Table 3). This estimated human dose to pregnant women is
approximately 6,000-fold lower than doses in lactating goats
(5e8 mg/kg/day) that resulted in milk concentrations approxi-
mately equal to the three reported breast milk concentrations in
the MAA report.
4. Glyphosate physico-chemical properties are not consistent
with a hypothesis that glyphosate bioaccumulates in breast
milk
The MAA report (Honeycutt and Rowlands, 2014) speculates
that the concentrations of glyphosate detected in human breast
milk are consistent with the behavior of certain lipophilic mole-
cules that bioaccumulate in milk. However, such speculation is
unwarranted when considered in context to glyphosate tox-
icokinetics and physico-chemico properties. As noted in the sec-
tions above, numerous toxicokinetic studies demonstrate that
glyphosate does not exhibit bioaccumulation potential in the body
or in breast milk. Whether administered in single or repeat doses,
systemically absorbed glyphosate is rapidly and completely
excreted into urine, generally within 48 h after termination of
dosing (Tables 1 and 2). Studies in lactating goats conﬁrm that only
0.01 to 0.03 percent of total administered glyphosate doses are
recovered in breast milk.
The lack of bioaccumulation demonstrated in animal tox-
icokinetic studies, in large part, can be attributed to the fact that
glyphosate is not lipophilic, distinguishing it from typicalbioaccumulative compounds. The pKa of the carboxylate moiety of
glyphosate is 2.3, indicating that glyphosate will be essentially
completely ionized at physiological pH. It is a well-established
toxicokinetic principle that highly ionized substances are unlikely
to distribute into lipophilic environments such as breast milk at
concentrations greater than those in blood. In addition, the octa-
nolewater partition coefﬁcient (log Pow) for glyphosate is 3.2 at a
pH of 5e9, indicating high hydrophilicity (partitions to water, not
lipids). In contrast, a log Pow value of 6.41 has been reported for
2,2ʹ,4,4ʹ,5-pentachlorobiphenyl, a prototypical polychlorinated
biphenyl (PCB) compound representative of extremely lipophilic
molecules typically associated with bioaccumulation (Brodsky and
Ballschmiter, 1988).
5. High-quality biomonitoring studies indicate that both
systemically absorbed and external doses of glyphosate are
well below U.S. and European reference-dose standards (e.g.,
acceptable daily intakes (ADIs) or reference doses (RfDs)
established as protective of public health, including nursing
children)
The U.S. EPA has established a glyphosate RfD of 1.75 mg/kg/day
based on maternal toxicity observed in rabbit developmental
toxicity studies at a no-observed-effect level (NOEL) dose of
175 mg/kg/day (total uncertainty factor of 100; U.S. EPA, 1993). The
European Food Safety Authority (EFSA) is currently re-evaluating
glyphosate and has recommended an Acceptable Daily Intake
(ADI) of 0.5 mg/kg/day (500 mg/kg/day) based on a rabbit maternal
toxicity NOEL of 50mg/kg/day and application of a total uncertainty
factor of 100 (Niemann et al., 2015).
The biomonitoring data described in Table 3 indicate that all
systemic and external doses of glyphosate estimated from glyph-
osate urine concentrations are well below the established RfD and
proposed ADI (reviewed in Niemann et al., 2015; for the EFSA ADI).
Both the mean and maximum systemic doses of glyphosate
calculated from Acquavella et al. (2004; Table 3), 0.11 or 8.3 mg/kg/
day, respectively, are well below the proposed EFSA ADI of 500 mg/
kg/day and the EPA RfD of 1,750 mg/kg. The highest mean external
dietary dose of 0.5 mg/kg/day and highest mean systemic dose of
0.1 mg/kg/day calculated from the Curwin et al. (2007) data are
likewise well below EPA and EFSA reference safety standards, as are
respective external and systemic doses of 1.0 and 0.2 mg/kg/day
estimated from food consumption data in pregnant women
(Table 3; McQueen et al., 2012). Importantly, even the maximum
external dose of 3.3 mg/kg/day and the systemic dose of 0.66 mg/kg/
day calculated from the MAA report remain well below both con-
tinents' regulatory accepted or recommended safety standards. In
addition, the 3.3 mg/kg/daymaximum external dose estimated from
the MAA data is based on the assumption that glyphosate absorp-
tion is limited to 20 percent based on oral absorption estimates
obtained from animal gavage toxicokinetic studies (Niemann et al.,
2015, Table 3). If glyphosate were to exhibit a higher percentage
absorption in humans due to dietary intake as compared to gavage
dosing in animals, e.g., 100 percent, the human external dose es-
timate would be equivalent to the 0.66 mg/kg/day daily dose esti-
mated from the urine biomonitoring sample.
Finally, even if the highly implausible breast milk concentra-
tions reported in the MAA report are accepted as real, the resulting
doses to nursing children would still not exceed safety standards
intended as health protective for infants. Thus, a 5-kg nursing in-
fant consuming 1 L of breast milk per day containing 166 mg/L
glyphosate would receive a daily glyphosate dose of 33 mg/kg/day,
which is below both EPA and proposed EFSA reference safety doses.
More realistically, given the analyses presented in the preceding
sections, infant exposures are likely to be substantially lower.
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The non-peer-reviewed and self-admitted preliminary MAA
biomonitoring report of Honeycutt and Rowlands (2014) does not
support the conclusion that glyphosate concentrations, detected in
either urine or breast milk samples obtained from a small number
of individuals across the U.S., present a health risk to the public,
including nursing children. In contrast, daily external and/or sys-
temically absorbed doses of glyphosate estimated from two more
robust biomonitoring studies (Acquavella et al., 2004; Curwin et al.,
2007) indicate that daily glyphosate doses are substantially below
health-protective reference standards (ADIs; RfDs), as were all
glyphosate doses estimated from the limited MAA urine bio-
monitoring dataset.
The MAA report also suggested that glyphosate bioaccumulates
in breast milk, based on detection of relatively high glyphosate
concentrations in breast milk samples from 3 of 10 women. How-
ever, the concentrations of glyphosate reported in breast milk are
highly implausible and are inconsistent with animal toxicokinetic
data demonstrating that glyphosate is not preferentially distributed
to or bioaccumulated in milk, and is rapidly cleared from the body
after either single- or multiple-dose administration. The tox-
icokinetic studies also indicate that glyphosate exposures esti-
mated from urine biomonitoring fall thousands-of-fold short of
external doses necessary to plausibly produce blood concentrations
sufﬁcient to result in the breast milk concentrations described in
the MAA report. Finally, the physico-chemical properties of
glyphosate are highly consistent with toxicokinetic evidence
demonstrating a low distribution to, and no bioaccumulation in,
breast milk.
In conclusion, integration of an array of animal toxicokinetic,
human biomonitoring/exposure, and physico-chemical property
data for glyphosate demonstrates that glyphosate does not bio-
accumulate in human breast milk, and that the high concentrations
of glyphosate reported in 3 of 10 women in the MAA report are
highly biologically implausible.
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